Acadia Healthcare Company, Inc. (ACHC) is a publicly traded Healthcare sector company. As of July 5, 2026, ACHC trades at $31.91 with a market cap of $2.93B and a P/E ratio of -2.62. ACHC moved +2.10% today. Year to date, ACHC is +118.41%; over the trailing twelve months it is +37.60%. Its 52-week range spans $11.43 to $47.08. Analyst consensus is buy with an average price target of $29.00. Rallies surfaces ACHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Acadia Healthcare’s Price Target Raised to $20 as Q4 Revenue Hits $821.5M: Barclays lifted Acadia Healthcare’s price target to $20 from $14, maintaining an Equal Weight rating after the company reported Q4 revenue of $821.5 million, up 6.1% year-over-year. Adjusted EBITDA reached $99.8 million while adjusted net income was $6.1 million, and 2026 revenue is guided to $3.37–$3.45 billion.
| Metric | Value |
|---|---|
| Price | $31.91 |
| Market Cap | $2.93B |
| P/E Ratio | -2.62 |
| EPS | $-12.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $47.08 |
| 52-Week Low | $11.43 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.31B |
| Net Income | $-1.09B |
| Gross Margin | 0.00% |
11 analysts cover ACHC: 0 strong buy, 7 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $29.00.